Purchases and Sales Made in Q3 2022 in Puma Biotechnology, Inc. (PBYI)
This table provides information about the institutional ownership of Puma Biotechnology, Inc. (PBYI) during Q3 2022. The information is specifically focused on institutions that hold shares of PUMA BIOTECHNOLOGY, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-24.9K- 5.99% |
$56.6K - $95.8K
|
392K
$1.09M
|
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-41K- 2.15% |
$93K - $157K
|
1.86M
$5.18M
|
|
|
Nov 14, 2022
Q3 2022
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-45.8K- 65.49% |
$104K - $176K
|
24.1K
$67.1K
|
|
|
Nov 14, 2022
Q3 2022
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-70.6K- 45.78% |
$160K - $271K
|
83.6K
$232K
|
|
|
Nov 14, 2022
Q3 2022
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-85.9K- 82.46% |
$195K - $330K
|
18.3K
$50.8K
|
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-89.5K- 29.89% |
$203K - $344K
|
210K
$584K
|
|
|
Nov 10, 2022
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-101K- 45.89% |
$230K - $389K
|
120K
$332K
|
|
|
May 14, 2024
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-101K- 45.89% |
$230K - $389K
|
120K
$332K
|
|
|
Nov 01, 2022
Q3 2022
|
Rice Hall James & Associates, LLC
|
SELL
|
- |
-119K- 23.42% |
$269K - $455K
|
388K
$1.08M
|
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-177K- 8.97% |
$402K - $681K
|
1.8M
$5M
|
|
|
Nov 14, 2022
Q3 2022
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-422K- 43.91% |
$957K - $1.62M
|
539K
$1.5M
|
|
|
Nov 14, 2022
Q3 2022
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-500K- 33.33% |
$1.14M - $1.92M
|
1M
$2.78M
|